Is treatment of nephropathy in type 1 diabetes efficacious but ineffective?

Journal of the American Society of Nephrology

Volumn 22, Issue 3, 2011, Pages 402-404

  Nelson, Robert G ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; CARDIOVASCULAR DISEASE; EDITORIAL; HEALTH CARE PERSONNEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR;

EID: 79952349604     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011010076     Document Type: Editorial

References (14)

1. Borch-Johnsen K, Andersen PK, Deckert T: The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28: 590-596, 1985 (Pubitemid 15017393)
2. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: Effect of proteinuria on mortality in NIDDM. Diabetes 37: 1499-1504, 1988
3. Groop PH, Thomas MC, Moran JL, Waden J, Thorn LM, Makinen VP, Rosengard-Barlund M, Saraheimo M, Hietala K, Heikkila O, Forsblom C: The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58: 1651-1658, 2009
4. Orchard TJ, Secrest AM, Miller RG, Costacou T: In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: A report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53: 2312-2319, 2010
5. Myers OB, Adams C, Rohrscheib MR, Servilla KS, Miskulin D, Bedrick EJ, Zager PG: Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol 21: 1970-1978, 2010
6. Karalliedde J, Viberti G: Proteinuria in diabetes: Bystander or pathway to cardiorenal disease? J Am Soc Nephrol 21: 2020-2027, 2010
7. Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Tolonen N, Saraheimo M, Gordin D, Moran JL, Thomas MC, Groop PH, Group, on behalf of the FinnDiane Study Group USRDS 2010 Annual Data Report: Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 22: 537-544, 2011
8. Rosolowsky RT, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS: Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 22: 545-553, 2011
9. Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH: Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study. Kidney Int 68: 1250-1257, 2005 (Pubitemid 43246444)
10. Parving HH, Jacobsen P, Rossing K, Smidt UM, Hommel E, Rossing P: Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy. Kidney Int 49: 1778-1782, 1996 (Pubitemid 26186611)
11. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
12. Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG: Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians. JAMA 296: 421-426, 2006 (Pubitemid 44127526)
13. Pavkov ME, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Nelson RG: Effect of intrauterine diabetes exposure on the incidence of end-stage renal disease in young adults with type 2 diabetes. Diabetes Care 33: 2396-2398, 2010
14. Pavkov ME, Knowler WC, Bennett PH, Looker HC, Krakoff J, Nelson RG: Increasing incidence of proteinuria and declining incidence of end-stage renal disease in diabetic Pima Indians. Kidney Int 70: 1840-1846, 2006